Developmental demands contribute to early neuromuscular degeneration in CMT2D mice.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
23 07 2020
Historique:
received: 21 05 2020
accepted: 13 07 2020
revised: 10 07 2020
entrez: 25 7 2020
pubmed: 25 7 2020
medline: 26 3 2021
Statut: epublish

Résumé

Dominantly inherited, missense mutations in the widely expressed housekeeping gene, GARS1, cause Charcot-Marie-Tooth type 2D (CMT2D), a peripheral neuropathy characterised by muscle weakness and wasting in limb extremities. Mice modelling CMT2D display early and selective neuromuscular junction (NMJ) pathology, epitomised by disturbed maturation and neurotransmission, leading to denervation. Indeed, the NMJ disruption has been reported in several different muscles; however, a systematic comparison of neuromuscular synapses from distinct body locations has yet to be performed. We therefore analysed NMJ development and degeneration across five different wholemount muscles to identify key synaptic features contributing to the distinct pattern of neurodegeneration in CMT2D mice. Denervation was found to occur along a distal-to-proximal gradient, providing a cellular explanation for the greater weakness observed in mutant Gars hindlimbs compared with forelimbs. Nonetheless, muscles from similar locations and innervated by axons of equivalent length showed significant differences in neuropathology, suggestive of additional factors impacting on site-specific neuromuscular degeneration. Defective NMJ development preceded and associated with degeneration, but was not linked to a delay of wild-type NMJ maturation processes. Correlation analyses indicate that muscle fibre type nor synaptic architecture explain the differential denervation of CMT2D NMJs, rather it is the extent of post-natal synaptic growth that predisposes to neurodegeneration. Together, this work improves our understanding of the mechanisms driving synaptic vulnerability in CMT2D and hints at pertinent pathogenic pathways.

Identifiants

pubmed: 32703932
doi: 10.1038/s41419-020-02798-y
pii: 10.1038/s41419-020-02798-y
pmc: PMC7378196
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

564

Subventions

Organisme : Medical Research Council
ID : MR/S006990/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103191/Z/13/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107116/Z/15/Z
Pays : United Kingdom

Références

Reilly, M. M., Murphy, S. M. & Laurá, M. Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst.16, 1–14 (2011).
pubmed: 21504497 doi: 10.1111/j.1529-8027.2011.00324.x
Pipis, M., Rossor, A. M., Laura, M. & Reilly, M. M. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges. Nat. Rev. Neurol.15, 644–656 (2019).
pubmed: 31582811 doi: 10.1038/s41582-019-0254-5
Prior, R., van Helleputte, L., Benoy, V. & van den Bosch, L. Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol. Dis.105, 300–320 (2017).
pubmed: 28238949 doi: 10.1016/j.nbd.2017.02.009
Beijer, D., Sisto, A., van Lent, J., Baets, J. & Timmerman, V. Defects in axonal transport in inherited neuropathies. J. Neuromuscul. Dis.6, 401–419 (2019).
pubmed: 31561383 pmcid: 6918914 doi: 10.3233/JND-190427
Sleigh, J. N., Rossor, A. M., Fellows, A. D., Tosolini, A. P. & Schiavo, G. Axonal transport and neurological disease. Nat. Rev. Neurol.15, 691–703 (2019).
pubmed: 31558780 doi: 10.1038/s41582-019-0257-2
Antonellis, A. et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet.72, 1293–1299 (2003).
pubmed: 12690580 pmcid: 1180282 doi: 10.1086/375039
Sivakumar, K. et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain128, 2304–2314 (2005).
pubmed: 16014653 doi: 10.1093/brain/awh590
Antonellis, A., Goldfarb, L. G. & Sivakumar, K. in GeneReviews® (eds. Adam, M. P. et al.) (University of Washington, Seattle, 2018).
Motley, W. W. et al. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet.7, e1002399 (2011).
pubmed: 22144914 pmcid: 3228828 doi: 10.1371/journal.pgen.1002399
Boczonadi, V., Jennings, M. J. & Horvath, R. The role of tRNA synthetases in neurological and neuromuscular disorders. FEBS Lett.592, 703–717 (2018).
pubmed: 29288497 pmcid: 5873386 doi: 10.1002/1873-3468.12962
Wei, N., Zhang, Q. & Yang, X.-L. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases. J. Biol. Chem.294, 5321–5339 (2019).
pubmed: 30643024 pmcid: 6462521 doi: 10.1074/jbc.REV118.002955
Antonellis, A. & Green, E. D. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu. Rev. Genomics Hum. Genet.9, 87–107 (2008).
pubmed: 18767960 doi: 10.1146/annurev.genom.9.081307.164204
Alexandrova, J., Paulus, C., Rudinger-Thirion, J., Jossinet, F. & Frugier, M. Elaborate uORF/IRES features control expression and localization of human glycyl-tRNA synthetase. RNA Biol.12, 1301–1313 (2015).
pubmed: 26327585 pmcid: 4829322 doi: 10.1080/15476286.2015.1086866
Boczonadi, V. et al. Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons. Hum. Mol. Genet.27, 2187–2204 (2018).
pubmed: 29648643 pmcid: 5985729 doi: 10.1093/hmg/ddy127
He, W. et al. Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening. Proc. Natl Acad. Sci. USA108, 12307–12312 (2011).
pubmed: 21737751 doi: 10.1073/pnas.1104293108
He, W. et al. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature526, 710–714 (2015).
pubmed: 26503042 pmcid: 4754353 doi: 10.1038/nature15510
Sleigh, J. N. et al. Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations. Proc. Natl Acad. Sci. USA114, E3324–E3333 (2017).
pubmed: 28351971 doi: 10.1073/pnas.1614557114
Park, M. C. et al. Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc. Natl Acad. Sci. USA109, E640–E647 (2012).
pubmed: 22345558 doi: 10.1073/pnas.1200194109
Grice, S. J. et al. Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology. Hum. Mol. Genet.24, 4397–4406 (2015).
pubmed: 25972375 pmcid: 4492401 doi: 10.1093/hmg/ddv176
Court, F. A., Brophy, P. J. & Ribchester, R. R. Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice. Glia56, 471–479 (2008).
pubmed: 18205176 pmcid: 4335188 doi: 10.1002/glia.20620
Ang, E.-T. et al. Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease. J. Neuropathol. Exp. Neurol.69, 281–293 (2010).
pubmed: 20142762 doi: 10.1097/NEN.0b013e3181d1e60f
Scurry, A. N. et al. Structural and functional abnormalities of the neuromuscular junction in the Trembler-J homozygote mouse model of congenital hypomyelinating neuropathy. J. Neuropathol. Exp. Neurol.75, 334–346 (2016).
pubmed: 26921370 pmcid: 4845671 doi: 10.1093/jnen/nlw004
Sabblah, T. T. et al. A novel mouse model carrying a human cytoplasmic dynein mutation shows motor behavior deficits consistent with Charcot-Marie-Tooth type 2O disease. Sci. Rep.8, 1739 (2018).
pubmed: 29379136 pmcid: 5789002 doi: 10.1038/s41598-018-20081-1
Cipriani, S. et al. Neuromuscular junction changes in a mouse model of Charcot-Marie-Tooth disease type 4C. Int. J. Mol. Sci. 19, 4072 (2018).
Soh, M. S. et al. Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans. PLoS ONE15, e0231600 (2020).
pubmed: 32294113 pmcid: 7159224 doi: 10.1371/journal.pone.0231600
Seburn, K. L., Nangle, L. A., Cox, G. A., Schimmel, P. & Burgess, R. W. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron51, 715–726 (2006).
pubmed: 16982418 doi: 10.1016/j.neuron.2006.08.027
Achilli, F. et al. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model. Mech.2, 359–373 (2009).
pubmed: 19470612 pmcid: 2707104 doi: 10.1242/dmm.002527
Sleigh, J. N., Grice, S. J., Burgess, R. W., Talbot, K. & Cader, M. Z. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum. Mol. Genet.23, 2639–2650 (2014).
pubmed: 24368416 doi: 10.1093/hmg/ddt659
Spaulding, E. L. et al. Synaptic deficits at neuromuscular junctions in two mouse models of Charcot-Marie-Tooth type 2d. J. Neurosci.36, 3254–3267 (2016).
pubmed: 26985035 pmcid: 4792937 doi: 10.1523/JNEUROSCI.1762-15.2016
Morelli, K. H. et al. Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models. J. Clin. Invest.129, 5568–5583 (2019).
pubmed: 31557132 pmcid: 6877339 doi: 10.1172/JCI130600
Grice, S. J., Sleigh, J. N. & Cader, M. Z. Plexin-semaphorin signaling modifies neuromuscular defects in a Drosophila model of peripheral neuropathy. Front. Mol. Neurosci.11, 55 (2018).
Mech, A. M., Brown, A. L., Schiavo, G. & Sleigh, J. N. Morphological variability is greater at developing than mature mouse neuromuscular junctions. J. Anat. https://doi.org/10.1111/joa.13228 (2020).
doi: 10.1111/joa.13228 pubmed: 32533580 pmcid: 7495279
Sleigh, J. N., Burgess, R. W., Gillingwater, T. H. & Cader, M. Z. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles. J. Neurosci. Methods227, 159–165 (2014).
pubmed: 24530702 pmcid: 4120659 doi: 10.1016/j.jneumeth.2014.02.005
Sleigh, J. N. et al. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis. Sci. Rep.7, 9216 (2017).
pubmed: 28835631 pmcid: 5569042 doi: 10.1038/s41598-017-10005-w
Sleigh, J. N., Mech, A. M., Aktar, T., Zhang, Y. & Schiavo, G. Altered sensory neuron development in CMT2D mice is site-specific and linked to increased GlyRS levels. Front. Cell. Neurosci. https://doi.org/10.3389/fncel.2020.00232 (2020).
doi: 10.3389/fncel.2020.00232 pubmed: 32848623 pmcid: 7431706
Murray, L., Gillingwater, T. H. & Kothary, R. Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis. J. Vis. Exp. e51162 https://doi.org/10.3791/51162 (2014).
Sanes, J. R. & Lichtman, J. W. Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci.22, 389–442 (1999).
pubmed: 10202544 doi: 10.1146/annurev.neuro.22.1.389
Bloch-Gallego, E. Mechanisms controlling neuromuscular junction stability. Cell Mol. Life Sci.72, 1029–1043 (2015).
pubmed: 25359233 doi: 10.1007/s00018-014-1768-z
Marques, M. J., Conchello, J. A. & Lichtman, J. W. From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J. Neurosci.20, 3663–3675 (2000).
pubmed: 10804208 pmcid: 6772702 doi: 10.1523/JNEUROSCI.20-10-03663.2000
Bradley, S. A., Lyons, P. R. & Slater, C. R. The epitrochleoanconeus muscle (ETA) of the mouse: a useful muscle for the study of motor innervation in vitro. J. Physiol.415, 3 (1989).
Tarpey, M. D. et al. Characterization and utilization of the flexor digitorum brevis for assessing skeletal muscle function. Skelet. Muscle8, 14 (2018).
pubmed: 29665848 pmcid: 5905177 doi: 10.1186/s13395-018-0160-3
Nijssen, J., Comley, L. H. & Hedlund, E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol.133, 863–885 (2017).
pubmed: 28409282 pmcid: 5427160 doi: 10.1007/s00401-017-1708-8
Delp, M. D. & Duan, C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J. Appl. Physiol.80, 261–270 (1996).
pubmed: 8847313 doi: 10.1152/jappl.1996.80.1.261
Smith, I. C. et al. Potentiation in mouse lumbrical muscle without myosin light chain phosphorylation: is resting calcium responsible? J. Gen. Physiol.141, 297–308 (2013).
pubmed: 23401574 pmcid: 3581688 doi: 10.1085/jgp.201210918
Russell, K. A., Ng, R., Faulkner, J. A., Claflin, D. R. & Mendias, C. L. Mouse forepaw lumbrical muscles are resistant to age-related declines in force production. Exp. Gerontol.65, 42–45 (2015).
pubmed: 25762422 pmcid: 4397162 doi: 10.1016/j.exger.2015.03.003
Jones, R. A. et al. NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction. Open Biol. 6, 160240 (2016).
Werheid, F. et al. Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? Brain Behav.6, e00451 (2016).
pubmed: 27088055 pmcid: 4782242 doi: 10.1002/brb3.451
Boyd, P. J. et al. Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy. PLoS Genet.13, e1006744 (2017).
pubmed: 28426667 pmcid: 5417717 doi: 10.1371/journal.pgen.1006744
Le Masson, G., Przedborski, S. & Abbott, L. F. A computational model of motor neuron degeneration. Neuron83, 975–988 (2014).
pubmed: 25088365 pmcid: 4167823 doi: 10.1016/j.neuron.2014.07.001
Lee, Y. I. Developmental neuromuscular synapse elimination: activity-dependence and potential downstream effector mechanisms. Neurosci. Lett.718, 134724 (2020).
pubmed: 31877335 doi: 10.1016/j.neulet.2019.134724
Gillingwater, T. H. & Ribchester, R. R. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from Wld
pubmed: 15034273 doi: 10.1023/B:NEUR.0000020629.51673.f5
Son, Y. J. & Thompson, W. J. Nerve sprouting in muscle is induced and guided by processes extended by Schwann cells. Neuron14, 133–141 (1995).
pubmed: 7826631 doi: 10.1016/0896-6273(95)90247-3
Orr, B. O. et al. Presynaptic homeostasis opposes disease progression in mouse models of ALS-like degeneration: evidence for homeostatic neuroprotection. Neuron107, 95–111 (2020).
Ayoob, J. C., Terman, J. R. & Kolodkin, A. L. Drosophila Plexin B is a Sema-2a receptor required for axon guidance. Development133, 2125–2135 (2006).
pubmed: 16672342 doi: 10.1242/dev.02380
Orr, B. O., Fetter, R. D. & Davis, G. W. Retrograde semaphorin-plexin signalling drives homeostatic synaptic plasticity. Nature550, 109–113 (2017).
pubmed: 28953869 pmcid: 5907800 doi: 10.1038/nature24017
Gonzalez, M. et al. Disruption of TrkB-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron24, 567–583 (1999).
pubmed: 10595510 doi: 10.1016/S0896-6273(00)81113-7
Garcia, N. et al. Involvement of brain-derived neurotrophic factor (BDNF) in the functional elimination of synaptic contacts at polyinnervated neuromuscular synapses during development. J. Neurosci. Res.88, 1406–1419 (2010).
pubmed: 20029969
Je, H. S. et al. Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses. Proc. Natl Acad. Sci. USA109, 15924–15929 (2012).
pubmed: 23019376 doi: 10.1073/pnas.1207767109
Nadal, L. et al. Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction. Mol. Brain9, 67 (2016).
pubmed: 27339059 pmcid: 4917939 doi: 10.1186/s13041-016-0248-9
Katz, E., Protti, D. A., Ferro, P. A., Rosato Siri, M. D. & Uchitel, O. D. Effects of Ca
doi: 10.1038/sj.bjp.0701290
Santafé, M. M., Garcia, N., Lanuza, M. A., Uchitel, O. D. & Tomás, J. Calcium channels coupled to neurotransmitter release at dually innervated neuromuscular junctions in the newborn rat. Neuroscience102, 697–708 (2001).
pubmed: 11226706 doi: 10.1016/S0306-4522(00)00507-8
Mantilla, C. B., Zhan, W.-Z. & Sieck, G. C. Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve29, 381–386 (2004).
pubmed: 14981737 doi: 10.1002/mus.10558
Dombert, B. et al. BDNF/trkB induction of calcium transients through Ca
pubmed: 29163025 pmcid: 5670157 doi: 10.3389/fnmol.2017.00346
Schmieg, N., Menendez, G., Schiavo, G. & Terenzio, M. Signalling endosomes in axonal transport: travel updates on the molecular highway. Semin. Cell Dev. Biol.27, 32–43 (2014).
pubmed: 24171925 doi: 10.1016/j.semcdb.2013.10.004
Villarroel-Campos, D., Schiavo, G. & Lazo, O. M. The many disguises of the signalling endosome. FEBS Lett.592, 3615–3632 (2018).
pubmed: 30176054 pmcid: 6282995 doi: 10.1002/1873-3468.13235
Mo, Z. et al. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy. Nat. Commun.9, 1007 (2018).
pubmed: 29520015 pmcid: 5843656 doi: 10.1038/s41467-018-03461-z
Deinhardt, K. et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron52, 293–305 (2006).
pubmed: 17046692 doi: 10.1016/j.neuron.2006.08.018
Puls, I. et al. Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455–456 (2003).
Verhoeven, K. et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet.72, 722–727 (2003).
pubmed: 12545426 pmcid: 1180247 doi: 10.1086/367847
Fellows, A. D., Rhymes, E. R., Gibbs, K. L., Greensmith, L. & Schiavo, G. IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons. EMBO Rep.21, e49129 (2020).
pubmed: 32030864 pmcid: 7054680 doi: 10.15252/embr.201949129
Wang, T. et al. Flux of signalling endosomes undergoing axonal retrograde transport is encoded by presynaptic activity and TrkB. Nat. Commun.7, 12976 (2016).
pubmed: 27687129 pmcid: 5427517 doi: 10.1038/ncomms12976
Allodi, I. et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci. Rep.6, 25960 (2016).
pubmed: 27180807 pmcid: 4867585 doi: 10.1038/srep25960
Pathak, A., Clark, S., Bronfman, F. C., Deppmann, C. D. & Carter, B. D. Long-distance regressive signaling in neural development and disease. Wiley Interdiscip. Rev. Dev. Biol. e382 (2020). https://doi.org/10.1002/wdev.382
Mantilla, C. B. et al. TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions. J. Appl. Physiol.117, 910–920 (2014).
pubmed: 25170066 pmcid: 4199990 doi: 10.1152/japplphysiol.01386.2013

Auteurs

James N Sleigh (JN)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. j.sleigh@ucl.ac.uk.
UK Dementia Research Institute, University College London, London, WC1E 6BT, UK. j.sleigh@ucl.ac.uk.

Aleksandra M Mech (AM)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.

Giampietro Schiavo (G)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
UK Dementia Research Institute, University College London, London, WC1E 6BT, UK.
Discoveries Centre for Regenerative and Precision Medicine, University College London Campus, London, WC1N 3BG, UK.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH